×
About 67,266 results

ALLMedicine™ Colitis Center

Research & Reviews  32,073 results

Impaired fertility in Women with Inflammatory Bowel Disease: A National Cohort Study fr...
https://doi.org/10.1093/ecco-jcc/jjaa191
Journal of Crohn's & Colitis; Druvefors E, Landerholm K et. al.

Sep 19th, 2020 - Inflammatory bowel disease (IBD) has been associated with reduced female fertility. We analyze fertility in a national cohort of women with IBD. Assessment of fertility in women with IBD aged 15-44 years in 1964-2014, identified from the Swedish N...

A decrease in the tear secretion volume in a mouse model with ulcerative colitis.
https://doi.org/10.1080/15569527.2020.1825471
Cutaneous and Ocular Toxicology; Sekijima H, Hiramoto K et. al.

Sep 18th, 2020 - STRUCTURED ABSTRACTPurpose/aim of the study: Dry eye syndrome is known to develop from several systemic inflammatory diseases. Although dry eye may develop due to extraintestinal complications of ulcerative colitis (UC), the pathogenesis is not we...

Tofacitinib for the Treatment of Ulcerative Colitis, Alopecia Universalis, and Atopic D...
https://doi.org/10.1093/ibd/izaa243
Inflammatory Bowel Diseases; Honap S, Cookson H et. al.

Sep 18th, 2020 - Tofacitinib for the Treatment of Ulcerative Colitis, Alopecia Universalis, and Atopic Dermatitis: One Drug, Three Diseases.|2020|Honap S,Cookson H,Sharma E,Samaan MA,Irving PM,|

Improving Animal Model of Induced Colitis by Acetic Acid in Terms of Fibrosis and Infla...
https://doi.org/10.1080/08941939.2020.1821844
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research; Bahrami G, Malekshahi H et. al.

Sep 18th, 2020 - Fifty rats were randomly separated into five groups (n = 10) with different durations (30 s, 5, 10, and 20 min) of exposure of the colon to 4% acetic acid and colitis was investigated for 0-9 days. The extent of the mucosal ulcers, colon tissue th...

Extracellular vesicles derived from human placental mesenchymal stem cells alleviate ex...
https://doi.org/10.3892/ijmm.2020.4679
International Journal of Molecular Medicine; Duan L, Huang H et. al.

Sep 18th, 2020 - Mesenchymal stem cells (MSCs) are pluripotent cells that can be applied to the treatment of immune disorders, including inflammatory bowel disease (IBD). The therapeutic effects of MSCs have been mostly attributed to the secretion of soluble facto...

see more →

Guidelines  111 results

Spotlight: Management of Moderate-to-Severe Ulcerative Colitis.
https://doi.org/10.1053/j.gastro.2020.03.012
Gastroenterology Feuerstein JD, Isaacs KL et. al.

Mar 9th, 2020 - Spotlight: Management of Moderate-to-Severe Ulcerative Colitis.|2020|Feuerstein JD,Isaacs KL,Schneider Y,Siddique SM,Falck-Ytter Y,|

AGA Technical Review on the Management of Moderate to Severe Ulcerative Colitis.
https://doi.org/10.1053/j.gastro.2020.01.007
Gastroenterology Singh S, Allegretti JR et. al.

Jan 16th, 2020 - A subset of patients with ulcerative colitis (UC) present with, or progress to, moderate to severe disease activity. These patients are at high risk for colectomy, hospitalization, corticosteroid dependence, and serious infections. The risk of lif...

AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Col...
https://doi.org/10.1053/j.gastro.2020.01.006
Gastroenterology Feuerstein JD, Isaacs KL et. al.

Jan 16th, 2020 - AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis.|2020|Feuerstein JD,Isaacs KL,Schneider Y,Siddique SM,Falck-Ytter Y,|

Management of ulcerative colitis: summary of updated NICE guidance.
https://doi.org/10.1136/bmj.l5897
BMJ (Clinical Research Ed.); Abdulrazeg O, Li B et. al.

Oct 29th, 2019 - Management of ulcerative colitis: summary of updated NICE guidance.|2019|Abdulrazeg O,Li B,Epstein J, ,|drug therapy,methods,therapeutic use,drug therapy,drug therapy,

Janssen Announces U.S. FDA Approval of STELARA® (ustekinumab) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis
https://www.prnewswire.com/news-releases/janssen-announces-us-fda-approval-of-stelara-ustekinumab-for-the-treatment-of-adults-with-moderately-to-severely-active-ulcerative-colitis-300941913.html

Oct 20th, 2019 - The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration's (FDA) approval of STELARA® (ustekinumab) for the treatment of adult patients with moderately to severely active ulcerative colitis. T...

see more →

Drugs  785 results see all →

Clinicaltrials.gov  33,261 results

Impaired fertility in Women with Inflammatory Bowel Disease: A National Cohort Study fr...
https://doi.org/10.1093/ecco-jcc/jjaa191
Journal of Crohn's & Colitis; Druvefors E, Landerholm K et. al.

Sep 19th, 2020 - Inflammatory bowel disease (IBD) has been associated with reduced female fertility. We analyze fertility in a national cohort of women with IBD. Assessment of fertility in women with IBD aged 15-44 years in 1964-2014, identified from the Swedish N...

A decrease in the tear secretion volume in a mouse model with ulcerative colitis.
https://doi.org/10.1080/15569527.2020.1825471
Cutaneous and Ocular Toxicology; Sekijima H, Hiramoto K et. al.

Sep 18th, 2020 - STRUCTURED ABSTRACTPurpose/aim of the study: Dry eye syndrome is known to develop from several systemic inflammatory diseases. Although dry eye may develop due to extraintestinal complications of ulcerative colitis (UC), the pathogenesis is not we...

Tofacitinib for the Treatment of Ulcerative Colitis, Alopecia Universalis, and Atopic D...
https://doi.org/10.1093/ibd/izaa243
Inflammatory Bowel Diseases; Honap S, Cookson H et. al.

Sep 18th, 2020 - Tofacitinib for the Treatment of Ulcerative Colitis, Alopecia Universalis, and Atopic Dermatitis: One Drug, Three Diseases.|2020|Honap S,Cookson H,Sharma E,Samaan MA,Irving PM,|

Improving Animal Model of Induced Colitis by Acetic Acid in Terms of Fibrosis and Infla...
https://doi.org/10.1080/08941939.2020.1821844
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research; Bahrami G, Malekshahi H et. al.

Sep 18th, 2020 - Fifty rats were randomly separated into five groups (n = 10) with different durations (30 s, 5, 10, and 20 min) of exposure of the colon to 4% acetic acid and colitis was investigated for 0-9 days. The extent of the mucosal ulcers, colon tissue th...

Extracellular vesicles derived from human placental mesenchymal stem cells alleviate ex...
https://doi.org/10.3892/ijmm.2020.4679
International Journal of Molecular Medicine; Duan L, Huang H et. al.

Sep 18th, 2020 - Mesenchymal stem cells (MSCs) are pluripotent cells that can be applied to the treatment of immune disorders, including inflammatory bowel disease (IBD). The therapeutic effects of MSCs have been mostly attributed to the secretion of soluble facto...

see more →

News  925 results

Bristol Myers' treatment succeeds in late-stage bowel disease study
https://www.reuters.com/article/us-bristolmyers-study/bristol-myers-treatment-succeeds-in-late-stage-bowel-disease-study-idUSKBN2391F2

Jun 2nd, 2020 - (Reuters) - U.S. drugmaker Bristol Myers Squibb Co said on Tuesday its treatment Zeposia, which it gained through its $74 billion buyout of Celgene last year, met the main goals of a late-stage study testing it in patients with an inflammatory bow...

Higher dose of Gilead-Galapagos drug meets ulcerative colitis study goals
https://www.reuters.com/article/us-gilead-sciences-study/higher-dose-of-gilead-galapagos-drug-meets-ulcerative-colitis-study-goals-idUSKBN22W33F

May 20th, 2020 - (Reuters) - Gilead Sciences Inc (GILD.O) and partner Galapagos NV (GLPG.AS) said on Wednesday only a higher dose of their experimental drug filgotinib showed greater effectiveness than placebo in a pivotal study testing it in ulcerative colitis pa...

FMT appears safe and effective for IBD patients with recurrent C. difficile
https://www.mdedge.com/clinicianreviews/article/219653/gastroenterology/fmt-appears-safe-and-effective-ibd-patients?channel=27442
Will Pass

Mar 26th, 2020 - Fecal microbiota transplantation (FMT) appears safe and effective for treating recurrent Clostridioides difficile infection in patients with inflammatory bowel disease (IBD), according to an ongoing prospective trial. Most patients were cured of C.

SECURE-IBD registry traces COVID-19 in patients with Crohn’s, colitis
https://www.mdedge.com/familymedicine/article/219462/coronavirus-updates/secure-ibd-registry-traces-covid-19-patients?channel=27980
MDedge Internal Medicine; Neil Osterweil

Mar 23rd, 2020 - Gastroenterologists and other clinicians caring for patients with inflammatory bowel disease are being encouraged to report outcomes for pediatric and adult patients with IBD and COVID-19 infections to a new international registry. The Surveillanc.

AGA guideline favors biologics for moderate to severe ulcerative colitis
https://www.mdedge.com/gihepnews/article/218988/gastroenterology/aga-guideline-favors-biologics-moderate-severe-ulcerative?channel=69
Richard Mark Kirkner, MDedge News

Mar 13th, 2020 - For moderate to severe ulcerative colitis, treatment with any one of the leading biologic agents is superior to no treatment at all. To maintain long-term remission, the Janus kinase inhibitor tofacitinib 5 mg twice daily is preferred for most pat.

see more →

Patient Education  111 results see all →